Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-25-020160

CEO sold 2,253 shares at $6.45 ($14,523)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Shah Gaurav CEO 2025-05-20 Sale −2,253 $6.45 $14,523 786,806 D: show line 1 in the form
Open-market sales · 2,253 sh · avg $6.45 · $14,523
Loading xslF345X05/form4.xml…